Altered free radical metabolism in acute mountain sickness: Implications for dynamic cerebral autoregulation and blood-brain barrier function

Journal of Physiology

Volumn 587, Issue 1, 2009, Pages 73-85

  Bailey, D M ^a   Evans, K A ^a   James, P E ^b   Mceneny, J ^c   Young, I S ^c   Fall, L ^a   Gutowski, M ^a   Kewley, E ^d   Mccord, J M ^e   Møller, Kirsten ^f   Ainslie, P N ^g  

^a UNIVERSITY OF GLAMORGAN   (United Kingdom)

^b CARDIFF UNIVERSITY   (United Kingdom)

^c QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

^d UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^e UNIVERSITY OF COLORADO   (United States)

^f Rigshospitalet   (Denmark)

^g UNIVERSITY OF OTAGO   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

ASCORBIC ACID; FREE RADICAL; LIPID HYDROPEROXIDE; LOW DENSITY LIPOPROTEIN; NEURON SPECIFIC ENOLASE; NITRIC OXIDE;

ACUTE DISEASE; ADULT; ALTITUDE DISEASE; ARTICLE; AUTOREGULATION; BLOOD BRAIN BARRIER; BLOOD FLOW VELOCITY; BRAIN FUNCTION; BRAIN PERFUSION; CALCULATION; CLINICAL ARTICLE; ERYTHROCYTE; HEADACHE; HOMEOSTASIS; HUMAN; HYPOXEMIA; HYPOXIA; MALE; MEAN ARTERIAL PRESSURE; METABOLISM; METABOLITE; MIDDLE CEREBRAL ARTERY; OXIDATION REDUCTION STATE; OXIDATIVE STRESS; PLASMA; PRIORITY JOURNAL;

ACUTE DISEASE; ADULT; ALTITUDE SICKNESS; ANOXIA; BLOOD FLOW VELOCITY; BLOOD PRESSURE; BLOOD-BRAIN BARRIER; BRAIN; CEREBROVASCULAR CIRCULATION; FREE RADICALS; HEADACHE; HOMEOSTASIS; HUMANS; HYPOXIA, BRAIN; MALE; OXIDATIVE STRESS; YOUNG ADULT;

EID: 58149307891     PISSN: 00223751     EISSN: 14697793     Source Type: Journal    
DOI: 10.1113/jphysiol.2008.159855     Document Type: Article

References (74)

1. Aaslid R, Lindegaard K, Sorteberg W & Nornes H (1989). Cerebral autoregulation dynamics in humans. Stroke 20, 45-52.
2. Appenzeller O, Claydon VE, Gulli G, Qualls C, Slessarev M, Zenebe G, Gebremedhin A & Hainsworth R (2006). Cerebral vasodilatation to exogenous NO is a measure of fitness for life at altitude. Stroke 37, 1754-1758.
3. Appenzeller O, Minko T, Qualls C, Pozharov V, Gamboa J, Gamboa A & Wang Y (2005). Migraine in the Andes and headache at sea level. Cephalalgia 25, 1117-1121.
4. Bailey DM (2003). Radical dioxygen: From gas to (unpaired!) electrons. Adv Exp Med Biol 543, 201-221.
5. Bailey D (2004). Ascorbate, blood-brain barrier function and acute mountain sickness: A radical hypothesis. Wilderness Environ Med 15, 231-233.
6. Bailey DM, Davies B & Young IS (2001a). Intermittent hypoxic training: Implications for lipid peroxidation induced by acute normoxic exercise in active men. Clin Sci (Lond) 101, 465-475.
7. Bailey DM, Davies B, Young IS, Hullin DA & Seddon PS (2001b). A potential role for free radical-mediated skeletal muscle soreness in the pathophysiology of acute mountain sickness. Aviat Space Environ Med 72, 513-521.
8. Bailey DM, Lawrenson L, McEneny J, Young IS, James PE, Jackson SK, Henry R, Mathieu-Costello O, McCord JM & Richardson RS (2007). Electron paramagnetic spectroscopic evidence of exercise-induced free radical accumulation in human skeletal muscle. Free Radic Res 41, 182-190.
9. Bailey D, Raman S, McEneny J, Young I, Parham K, Hullin D, Davies B, McKeeman G, McCord J & Lewis M (2006a). Vitamin C prophylaxis promotes oxidative lipid damage during surgical ischemia-reperfusion. Free Radic Biol Med 40, 591-600.
10. Bailey DM, Roukens R, Knauth M, Kallenberg K, Christ S, Mohr A, Genius J, Storch-Hagenlocher B, Meisel F, McEneny J, Young IS, Steiner T, Hess K & Bartsch P (2006b). Free radical-mediated damage to barrier function is not associated with altered brain morphology in high-altitude headache. J Cereb Blood Flow Metab 26, 99-111.
11. Bartsch P, Bailey DM, Berger MM, Knauth M & Baumgartner RW (2004). Acute mountain sickness: Controversies, advances and future directions. High Altitude Med Biol 5, 110-124.
12. Bartsch P, Mairbaurl H, Maggiorini M & Swenson ER (2005). Physiological aspects of high-altitude pulmonary edema. J Appl Physiol 98, 1101-1110.
13. Beall CM (2007). Two routes to functional adaptation: Tibetan and Andean high-altitude natives. Proc Natl Acad Sci U S A 104, 8655-8660.
14. Buettner GR (1993). The pecking order of free radicals and antioxidants: lipid peroxidation, α-tocopherol, and ascorbate. Arch Biochem Biophys 300, 535-543.
15. Buettner GR & Jurkiewicz BA (1993). Ascorbate free radical as a marker of oxidative stress: An EPR study. Free Radic Biol Med 14, 49-55.
16. Burgoyne JR, Madhani M, Cuello F, Charles RL, Brennan JP, Schroder E, Browning DD & Eaton P (2007). Cysteine redox sensor in PKGIa enables oxidant-induced activation. Science 317, 1393-1397.
17. Catignani GL & Bieri JG (1983). Simultaneous determination of retinol and alpha-tocopherol in serum or plasma by liquid chromatography. Clin Chem 29, 708-712.
18. Clanton TL (2007). Hypoxia-induced reactive oxygen species formation in skeletal muscle. J Appl Physiol 102, 2379-2388.
19. Diehl RR, Linden D, Lucke D & Berlit P (1995). Phase relationship between cerebral blood flow velocity and blood pressure: A clinical test of autoregulation. Stroke 26, 1801-1804.
20. Doyle MP, Pickering RA, DeWeert TM, Hoekstra JW & Pater D (1981). Kinetics and mechanism of the oxidation of human deoxyhemoglobin by nitrites. J Biol Chem 256, 12393-12398.
21. Ewing JF & Janero DR (1998). Specific S-nitrosothiol (thionitrite) quantification as solution nitrite after vanadium (III) reduction and ozone-chemiluminescent detection. Free Radic Biol Med 25, 621-628.
22. Finkel T & Holbrook NJ (2000). Oxidants, oxidative stress and the biology of ageing. Nature 408, 239-247.
23. Fischer S, Clauss M, Wiesnet M, Renz D, Schaper W & Karliczek GF (1999). Hypoxia induces permeability in brain microvessel endothelial cells via VEGF and NO. Am J Physiol Cell Physiol 276, C812-C820.
24. Gryglewsky RJ, Palmer RM & Moncada S (1986). Superoxide anion is involved in the breakdown of endothelium-derived vascular relaxing factor. Nature 320, 454-456.
25. Guzy RD & Schumacker PT (2006). Oxygen sensing by mitochondria at complex III: The paradox of increased reactive oxygen species during hypoxia. Exp Physiol 91, 807-819.
26. Hackett PH, Rennie D & Levine HD (1976). The incidence, importance, and prophylaxis of acute mountain sickness. Lancet 2, 1149-1155.
27. Hackett PH & Roach RC (2001). High-altitude illness. N Engl J Med 345, 107-114.
28. Harman D (1956). Aging: A theory based on free radical and radiation chemistry. J Gerontol 11, 298-300.
29. Hasegawa K & Patterson LK (1978). Pulse radiolysis studies in model lipid systems: Formation and behavior of peroxy radicals in fatty acids. Photochem Photobiol 28, 817-823.
30. Hausladen A, Rafikov R, Angelo M, Singel DJ, Nudler E & Stamler JS (2007). Assessment of nitric oxide signals by triiodide chemiluminescence. Proc Natl Acad Sci U S A 104, 2157-2162.
31. Iversen HK, Olesen J & Tfelt-Hansen P (1989). Intravenous nitroglycerin as an experimental model of vascular headache. Basic characteristics. Pain 38, 17-24.
32. Iwasaki K-I, Levine BD, Zhang R, Zuckerman JH, Pawelczyk JA, Diedrich A, Ertl AC, Cox JF, Cooke WH, Giller CA, Ray CA, Lane LD, Buckey JC Jr, Baisch FJ, Eckberg DL, Robertson D, Biaggioni I & Blomqvist CG (2007). Human cerebral autoregulation before, during and after spaceflight. J Physiol 579, 799-810.
33. Jansen GFA, Krins A, Basnyat B, Bosch A & Odoom JA (2000). Cerebral autoregulation in subjects adapted and not adapted to high altitude. Stroke 31, 2314-2318.
34. Jia L, Bonaventura C, Bonaventura J & Stamler JS (1996). S-nitrosohaemoglobin: A dynamic activity of blood involved in vascular control. Nature 380, 221-226.
35. Jiang Q, Christen S, Shigenaga MK & Ames BN (2001). γ-Tocopherol, the major form of vitamin E in the US diet, deserves more attention. Am J Clin Nutr 74, 714-722.
36. Kallenberg K, Bailey DM, Christ S, Mohr A, Roukens R, Menold E, Steiner T, Bartsch P & Knauth M (2007). Magnetic resonance imaging evidence of cytotoxic cerebral edema in acute mountain sickness. J Cereb Blood Flow Metab 27, 1064-1071.
37. Kallenberg K, Dehnert C, Dorfler A, Schellinger PD, Bailey DM, Knauth M & Bartsch PD (2008). Microhemorrhages in nonfatal high-altitude cerebral edema. J Cereb Blood Flow Metab 28, 1635-1642.
38. Kanner AA, Marchi N, Fazio V, Mayberg MR, Koltz MT, Siomin V, Stevens GH, Masaryk T, Aumayr B, Ayumar B, Vogelbaum MA, Barnett GH & Janigro D (2003b). Serum S100β: A noninvasive marker of blood-brain barrier function and brain lesions. Cancer 97, 2806-2813.
39. Kanner A, Marchi N, Fazio V, Mayberg M, Koltz M, Siomin V, Stevens G, Masaryk T, Ayumar B, Vogelbaum M, Barnett G & Janigro D (2003a). Serum S100β: A noninvasive marker of blood-brain barrier function and brain lesions. Cancer 97, 2806-2813.
40. Kety SS & Schmidt CF (1948). The nitrous oxide method for the quantitative determination of cerebral blood flow in man: Theory, procedure and normal values. J Clin Invest 27, 476-484.
41. Lassen NA & Harper AM (1975). Letter: High-altitude cerebral oedema. Lancet 2, 1154.
42. Maher AR, Milsom AB, Gunaruwan P, Abozguia K, Ahmed I, Weaver RA, Thomas P, Ashrafian H, Born GVR, James PE & Frenneaux MP (2008). Hypoxic modulation of exogenous nitrite-induced vasodilation in humans. Circulation 117, 670-677.
43. Mansoor JK, Morrissey BM, Walby WF, Yoneda KY, Juarez M, Kajekar R, Severinghaus JW, Eldridge MW & Schelegle ES (2005). L-Arginine supplementation enhances exhaled NO, breath condensate VEGF, and headache at 4,342 m. High Alt Med Biol 6, 289-300.
44. Marchi N, Rasmussen P, Kapural M, Fazio V, Kight K, Mayberg M, Kanner A, Ayumar B, Albensi B, Cavaglia M & Janigro D (2003). Peripheral markers of brain damage and blood-brain barrier dysfunction. Restor Neurol Neurosci 21, 109-121.
45. McDowell I, McEneny J & Trimble E (1995). A rapid method for measurement of the susceptibility to oxidation of low-density lipoprotein. Ann Clin Biochem 32, 167-174.
46. Nauser T & Koppenol WH (2002). The rate constant of the reaction of superoxide with nitrogen monoxide: Approaching the diffusion limit. J Phys Chem A 106, 4084-4086.
47. Ogoh S, Brothers RM, Barnes Q, Eubank WL, Hawkins MN, Purkayastha S, O-Yurvati A & Raven PB (2005). The effect of changes in cardiac output on middle cerebral artery mean blood velocity at rest and during exercise. J Physiol 569, 697-704.
48. Panerai RB (2008). Cerebral autoregulation: From models to clinical applications. Cardiovasc Eng 8, 42-59.
49. Pryor WA, Houk KN, Foote CS, Fukuto JM, Ignarro LJ, Squadrito GL & Davies KJA (2006). Free radical biology and medicine: It's a gas, man!Am J Physiol Regul Integr Comp Physiol 291, R491-R511.
50. Rassaf T, Feelisch M & Kelm M (2004). Circulating NO pool: assessment of nitrite and nitroso species in blood and tissues. Free Radic Biol Med 36, 413-422.
51. Richalet JP, Hornych A, Rathat C, Aumont J, Larmignat P & Remy P (1991). Plasma prostaglandins, leukotrienes and thromboxane in acute high altitude hypoxia. Respir Physiol 85, 205-215.
52. Roach RC, Bartsch P, Hackett PH & Oelz O (1993). The Lake Louise acute mountain sickness scoring system. In Hypoxia and Molecular Medicine, ed. Sutton JR, Coates J & Houston CS, pp. 272-274. Queen City Printers, Burlington.
53. Roach RC & Hackett PH (2001). Frontiers of hypoxia research: Acute mountain sickness. J Exp Biol 204, 3161-3170.
54. Rogers SC, Khalatbari A, Gapper PW, Frenneaux MP & James PE (2005). Detection of human red blood cell bound nitric oxide. J Biol Chem. 280, 26720-26728.
55. Rogers SC, Khalatbari A, Datta BN, Ellery S, Paul V, Frenneaux MP & James PE (2007). NO metabolite flux across the human coronary circulation. Cardiovasc Res 75, 434-441.
56. Sammons EL, Samani NJ, Smith SM, Rathbone WE, Bentley S, Potter JF & Panerai RB (2007). Influence of noninvasive peripheral arterial blood pressure measurements on assessment of dynamic cerebral autoregulation. J Appl Physiol 103, 369-375.
57. Sampson JB, Cymerman A, Burse RL, Maher JT & Rock PB (1983). Procedures for the measurement of acute mountain sickness. Aviat Space Environ Med 54, 1063-1073.
58. Sanchez del Rio M & Moskowitz MA (1999). High altitude headache. Lessons from headaches at sea level. Adv Exp Med Biol 474, 145-153.
59. Schoonman GG, Sandor PS, Nirkko AC, Lange T, Jaermann T, Dydak U, Kremer C, Ferrari MD, Boesiger P & Baumgartner RW (2008). Hypoxia-induced acute mountain sickness is associated with intracellular cerebral edema: a 3 T magnetic resonance imaging study. J Cereb Blood Flow Metab 28, 198-206.
60. Sharma M & Buettner G (1993). Interaction of vitamin C and vitamin E during free radical stress in plasma: An ESR study. Free Radic Biol Med 14, 649-653.
61. Strecker T, Dux M & Messlinger K (2002). Nitric oxide releases calcitonin-gene-related peptide from rat dura mater encephali promoting increases in meningeal blood flow. J Vasc Res 39, 489-496.
62. Swartz HM, Khan N & Khramtsov VV (2007). Use of electron paramagnetic resonance spectroscopy to evaluate the redox state in vivo. Antioxid Redox Signal 9, 1757-1771.
63. Thurnham DI, Smith E & Flora PS (1988). Concurrent liquid-chromatographic assay of retinol, alpha-tocopherol, beta-carotene, alpha-carotene, lycopene, and beta-cryptoxanthin in plasma, with tocopherol acetate as internal standard. Clin Chem 34, 377-381.
64. Tiecks FP, Lam AM, Aaslid R & Newell DW (1995). Comparison of static and dynamic cerebral autoregulation measurements. Stroke 26, 1014-1019.
65. van Mil AHM, Spilt A, van Buchem MA, Bollen ELEM, Teppema L, Westendorp RGJ & Blauw GJ (2002). Nitric oxide mediates hypoxia-induced cerebral vasodilation in humans. J Appl Physiol 92, 962-966.
66. Van Osta A, Moraine J-J, Melot C, Mairbaurl H, Maggiorini M & Naeije R (2005). Effects of high altitude exposure on cerebral hemodynamics in normal subjects. Stroke 36, 557-560.
67. Vogelbaum MA, Masaryk T, Mazzone P, Mekhail T, Fazio V, McCartney S, Marchi N, Kanner A & Janigro D (2005). S100β as a predictor of brain metastases: Brain versus cerebrovascular damage. Cancer 104, 817-824.
68. Vuilleumier JP & Keck E (1993). Fluorimetric assay of vitamin C in biological materials using a centrifugal analyser with fluorescence attachment. J Micronutr Anal 5, 25-34.
69. White RP, Vallance P & Markus HS (2000). Effect of inhibition of nitric oxide synthase on dynamic cerebral autoregulation in humans. Clin Sci (Lond) 99, 555-560.
70. Wolff SP (1994). Ferrous ion oxidation in presence of ferric ion indicator xylenol orange for measurement of hydroperoxides. Methods Enzymol 233, 183-189.
71. Yang BK, Vivas EX, Reiter CD & Gladwin MT (2003). Methodologies for the sensitive and specific measurement of S-nitrosothiols, iron-nitrosyls, and nitrite in biological samples. Free Radic Res 37, 1-10.
72. Zagorac D, Yamaura K, Zhang C, Roman RJ & Harder DR (2005). The effect of superoxide anion on autoregulation of cerebral blood flow. Stroke 36, 2589-2594.
73. Zhang R, Wilson TE, Witkowski S, Cui J, Crandall CG & Levine BD (2004). Inhibition of nitric oxide synthase does not alter dynamic cerebral autoregulation in humans. Am J Physiol Heart Circ Physiol 286, H863-H869.
74. Zhang R, Zuckerman JH, Giller CA & Levine BD (1998). Transfer function analysis of dynamic cerebral autoregulation in humans. Am J Physiol Heart Circ Physiol 274, H233-H241.